Enteral Nutrition Market to Generate $12.29 Billion by 2027, States the Report by Allied Market Research

A lead analyst at AMR has highlighted that the enteral nutrition market across Asia-Pacific is anticipated to grow at the fastest CAGR during the forecast period.

Allied Market Research published a research report on the enteral nutrition market. The findings of the report state that the global market for enteral nutrition generated $6.76 billion in 2018, and is projected to reach $12.29 billion by 2027, witnessing a CAGR of 7.1% from 2020 to 2027. The report offers valuable information on changing market dynamics, major segments, top investment pockets, and competitive scenarios for market players, investors, shareholders, and new entrants.

“growth of the global Enteral nutrition market is driven by a rise in prevalence of chronic diseases such as diabetes, cancer and other chronic conditions which require appropriate nutrition for the management of disease, rise in geriatric population, the surge in the healthcare expenditure and steep growth in malnutrition cases,” said Onkar Sumant, Manager, Healthcare at Allied Market Research.

The report provides insights on drivers, restraints, and opportunities to help the market players in devising growth strategies and capitalizing on opportunities. An increase in the number of malnutrition cases, growth in incidences of chronic illness, and high adoption of enteral nutrition over parenteral nutrition propel the growth of the global enteral nutrition market. On the other hand, poor demand in underdeveloped countries impedes growth to some extent. However, untapped potential in emerging economies is expected to create lucrative opportunities for the key players in the industry.

The report also offers a detailed scenario of the impact of the Covid-19 pandemic on the enteral nutrition market globally. It is helpful for the market players, new entrants, and investors to determine strategies as per the current scenario and improvise the business model for the next few years. The outbreak of the pandemic heightened the demand for enteral nutrition owing to high nutritional risks among Covid-19 patients. The fact that the Covid-19 infected patients require intensive care management and nutritional deficits caused during the condition boosted the market growth. This, in turn, has paved the way for lucrative opportunities for the industry players. At the same time, the prolonged lockdown across the world and the temporary ban on international trade disrupted the supply chain. However, the market has now got back on track.?

The report offers detailed segmentation of the global enteral nutrition market based on protein composition, form, age group, distribution channel, and region. These insights are helpful for new as well as existing market players to capitalize on the fastest-growing and largest revenue-generating segments to accomplish growth in the future.

By protein composition, the standard protein diet accounted for the largest share in 2018, generating nearly three-fifths of the global market. On the other hand, the protein for diabetes care patient segment is projected to cite the fastest CAGR of 8.2% throughout the forecast period.

By distribution channel, the hospital sales segment had the lion's share in 2018, accounting for more than three-fifths of the global market revenue. Simultaneously, the online segment is projected estimated to manifest the fastest CAGR of 7.9% during the forecast period.

The global enteral nutrition market is assessed across several regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America garnered the highest share in 2018, contributing to around one-third of the global market revenue. However, Asia-Pacific is projected to cite the fastest CAGR of 8.2% from 2020 to 2027.

Leading market players of the global enteral nutrition market analyzed in the report include Abbott Laboratories, Fresenius Kabi AG, Hormel Foods Corporation, Victus, Inc., Global Health Products, Inc., Nestlé S.A., Meiji Holdings Co., Ltd., B. Braun Melsungen AG,?Reckitt Benckiser Group PLC., and Danone S.A.